Top Markets
Coin of the day
Spencer Pharmaceutical Inc. Spencer Pharmaceutical Inc.

Spencer Pharmaceutical Inc.

SPPH
Classement en actions #41285
Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms... Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms aimed at addressing neurological conditions. A core aspect of their expertise lies in the precise, controlled administration of existing therapeutic compounds for central nervous system disorders, such as Alzheimer's, Parkinson's disease, and various forms of brain cancer. Moreover, the company holds a proprietary slow-release drug delivery system, which is utilized for managing type-2 diabetes and arthritis, and holds promise for other medical applications. Its operations are predominantly located in North America and Europe. Spencer Pharmaceutical Inc. was established in 1998 and maintains its headquarters in Boston, Massachusetts.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$29.44K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Spencer Pharmaceutical Inc. (SPPH)

Catégorie

Ratio P/B pour Spencer Pharmaceutical Inc. (SPPH)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Spencer Pharmaceutical Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Spencer Pharmaceutical Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes